Mechanism of aspartame-induced antinociception in mice

Indian Journal of Pharmacology

Volumn 35, Issue 1, 2003, Pages 37-41

  Abdollahi, Mohammad ^a   Sarrafzadeh, J ^a   Nikfar, S ^b   Roshanzamir, F ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antinociceptive; NMDA; Pain; Sweetening agent

Indexed keywords

1 AMINO 1,3 CYCLOBUTANEDICARBOXYLIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; ASPARTAME; FORMALDEHYDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; SWEETENING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELECTIVITY; EXPERIMENTAL TEST; FOOD DRUG INTERACTION; INGESTION; MALE; MOUSE; NONHUMAN; PAIN;

EID: 0037317395     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nikfar S, Abdollahi M, Etemad F, Sharifzadeh M. Effects of sweetening agents on morphine-induced antinociception in mice by formalin-test. Gen Pharmacol 1997;29:583-6.
2. Abdollahi M, Nikfar S, Habibi L. Saccharin effects on morphine-induced antinociception in the mouse formalin test. Pharmacol Res 2000;42:255-9.
3. Nikfar S, Abdollahi M, Sarkarati F, Etemad F. Interaction between calcium channel blockers and sweetening agents on morphine induced antinociception in mice by formalin test. Gen Pharmacol 1998;31:431-5.
4. Abdollahi M, Nikfar S, Abdoli N. Potentiation by nitric oxide synthase inhibitor and calcium channel blocker of aspartame-induced antinociception in the mouse formalin test. Fund Clin Pharmacol 2001;15:117-23.
5. Ranney RE, Oppermann JA, Muldoon E. Comparative metabolism of aspartame in experimental animals and humans. J Toxicol Environ Health 1976;2:441-51.
6. Micromedex International Healthcare Series. Aspartame Neurologic Clinical Effects, Disk A, Toxicology Information, Poisindex, 2002, Volume 111.
7. Singh J, Gupta MC. Effect of aspartate and glutamate on nociception, catalepsy and core temperature in rats. Indian J Physiol Pharmacol 1997;41:123-8.
8. Lutfy K, Cai SX, Woodward RM, Weber E. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice. Pain 1997;70:31-40.
9. Hunskaar S, Fasmer OB, Hole K. Formalin test in mice, an useful technique for evaluating mild analgesics. J Neurosci Meth 1985;14:69-76.
10. Rosland JH, Tjølsen A, Mæhle B, Hole K. The formalin test in mice: Effect of formalin concentration. Pain 1990;42:235-42.
11. Christensen D, Idanpaan-Heikkila JJ, Guilbaud G, Kayser V. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy. Br J Pharmacol 1998;125:1641-50.
12. Coderre TJ, Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites. Pain 1994;59:353-9.
13. Sakurada T, Wako K, Sugiyama A, Sakurada C, Tan-No K, Kisara K, et al. Involvement of spinal NMDA receptors in capsaicin-induced nociception. Pharmacol Biochem Behav 1998;59:339-45.
14. Nasstrom J, Karlsson U, Post C. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur J Pharmacol 1992;212:21-9.
15. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 1992;12:3665-70.
16. Pan-Hou H, Suda Y, Ohe Y, Sumi M, Yoshioka M. Effect of aspartame on N-methyl-D-aspartate-sensitive L-[3H] glutamate binding sites in rat brain synaptic membranes. Brain Res 1990;520:351-3.